Greg Chopskie

FDA Proudly Announces Its First Approval Of An Interchangeable Biosimilar

When Compulsory Licenses Apparently Just Won't Do: The US Backs Waiver Of Rights To IP Relating To COVID-19

Delaware Provides More Insight Into The Scope Of The Rights Derived By A Patent Term Extension